SMTI
Price
$33.57
Change
-$0.47 (-1.38%)
Updated
Sep 5 closing price
Capitalization
298.85M
72 days until earnings call
TRUMY
Price
$17.85
Change
+$0.10 (+0.56%)
Updated
Sep 5 closing price
Capitalization
26.37B
61 days until earnings call
Interact to see
Advertisement

SMTI vs TRUMY

Header iconSMTI vs TRUMY Comparison
Open Charts SMTI vs TRUMYBanner chart's image
Sanara MedTech
Price$33.57
Change-$0.47 (-1.38%)
Volume$11.75K
Capitalization298.85M
Terumo
Price$17.85
Change+$0.10 (+0.56%)
Volume$118.77K
Capitalization26.37B
SMTI vs TRUMY Comparison Chart in %
Loading...
SMTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRUMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SMTI vs. TRUMY commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SMTI is a Buy and TRUMY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (SMTI: $33.57 vs. TRUMY: $17.85)
Brand notoriety: SMTI and TRUMY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: SMTI: 24% vs. TRUMY: 82%
Market capitalization -- SMTI: $298.85M vs. TRUMY: $26.37B
SMTI [@Pharmaceuticals: Other] is valued at $298.85M. TRUMY’s [@Pharmaceuticals: Other] market capitalization is $26.37B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $162.93B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SMTI’s FA Score shows that 0 FA rating(s) are green whileTRUMY’s FA Score has 0 green FA rating(s).

  • SMTI’s FA Score: 0 green, 5 red.
  • TRUMY’s FA Score: 0 green, 5 red.
According to our system of comparison, TRUMY is a better buy in the long-term than SMTI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SMTI’s TA Score shows that 6 TA indicator(s) are bullish while TRUMY’s TA Score has 5 bullish TA indicator(s).

  • SMTI’s TA Score: 6 bullish, 4 bearish.
  • TRUMY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SMTI is a better buy in the short-term than TRUMY.

Price Growth

SMTI (@Pharmaceuticals: Other) experienced а -0.27% price change this week, while TRUMY (@Pharmaceuticals: Other) price change was -0.67% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.24%. For the same industry, the average monthly price growth was +7.04%, and the average quarterly price growth was +16.54%.

Reported Earning Dates

SMTI is expected to report earnings on Nov 17, 2025.

TRUMY is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.24% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRUMY($26.4B) has a higher market cap than SMTI($299M). SMTI YTD gains are higher at: 1.114 vs. TRUMY (-8.462). TRUMY has higher annual earnings (EBITDA): 247B vs. SMTI (147K). TRUMY has more cash in the bank: 195B vs. SMTI (17M). SMTI has less debt than TRUMY: SMTI (45.5M) vs TRUMY (175B). TRUMY has higher revenues than SMTI: TRUMY (987B) vs SMTI (97.2M).
SMTITRUMYSMTI / TRUMY
Capitalization299M26.4B1%
EBITDA147K247B0%
Gain YTD1.114-8.462-13%
P/E RatioN/A33.44-
Revenue97.2M987B0%
Total Cash17M195B0%
Total Debt45.5M175B0%
FUNDAMENTALS RATINGS
SMTI vs TRUMY: Fundamental Ratings
SMTI
TRUMY
OUTLOOK RATING
1..100
1855
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
40
Fair valued
PROFIT vs RISK RATING
1..100
83100
SMR RATING
1..100
9699
PRICE GROWTH RATING
1..100
4258
P/E GROWTH RATING
1..100
10053
SEASONALITY SCORE
1..100
90n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TRUMY's Valuation (40) in the null industry is somewhat better than the same rating for SMTI (82). This means that TRUMY’s stock grew somewhat faster than SMTI’s over the last 12 months.

SMTI's Profit vs Risk Rating (83) in the null industry is in the same range as TRUMY (100). This means that SMTI’s stock grew similarly to TRUMY’s over the last 12 months.

SMTI's SMR Rating (96) in the null industry is in the same range as TRUMY (99). This means that SMTI’s stock grew similarly to TRUMY’s over the last 12 months.

SMTI's Price Growth Rating (42) in the null industry is in the same range as TRUMY (58). This means that SMTI’s stock grew similarly to TRUMY’s over the last 12 months.

TRUMY's P/E Growth Rating (53) in the null industry is somewhat better than the same rating for SMTI (100). This means that TRUMY’s stock grew somewhat faster than SMTI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SMTITRUMY
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
71%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
66%
Advances
ODDS (%)
Bullish Trend 11 days ago
78%
Bullish Trend 11 days ago
67%
Declines
ODDS (%)
Bearish Trend 9 days ago
80%
Bearish Trend 3 days ago
65%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
69%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
SMTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRUMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ADXRF0.030.02
+242.00%
ADX Energy Ltd.
XJNGF1.250.15
+13.73%
GOLDWIND SCIENCE & TECHNOLOGY CO LTD
UBOH34.840.84
+2.47%
United Bancshares, Inc.
CIIHF3.65N/A
N/A
Citic Securities Co., Ltd.
UBSFF10.01N/A
N/A
UbiSoft Entertainment Inc.

SMTI and

Correlation & Price change

A.I.dvisor indicates that over the last year, SMTI has been loosely correlated with A. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SMTI jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMTI
1D Price
Change %
SMTI100%
-1.38%
A - SMTI
47%
Loosely correlated
+0.21%
NTRA - SMTI
45%
Loosely correlated
+0.88%
ISRG - SMTI
44%
Loosely correlated
+2.71%
MTD - SMTI
44%
Loosely correlated
+1.39%
TWST - SMTI
44%
Loosely correlated
+0.51%
More

TRUMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRUMY has been loosely correlated with HOCPY. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TRUMY jumps, then HOCPY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRUMY
1D Price
Change %
TRUMY100%
+0.56%
HOCPY - TRUMY
51%
Loosely correlated
+3.59%
SSMXY - TRUMY
45%
Loosely correlated
+2.26%
SMTI - TRUMY
43%
Loosely correlated
-1.38%
OLYMY - TRUMY
40%
Loosely correlated
+4.87%
AZTA - TRUMY
39%
Loosely correlated
+2.64%
More